Carl Zeiss Meditec has appointed Andrew Ihan Chang to head the global sales organization of its newly consolidated group. In August of this year, Carl Zeiss Meditec consolidated its ophthalmic diagnostic and surgical business into a single Strategic Business Unit (SBU) - Global Ophthalmic Devices - led by Jim Mazzo. Chang will head the Global Sales organization for the newly consolidated SBU, which is comprised of surgical ophthalmology, ophthalmic diagnostics and refractive lasers. Previously, Chang was general manager and senior vice president for Bausch + Lomb Surgical, where he led marketing, sales, operations and business development for the U.S. market. Before that, he worked at Optimedica/Abbott Medical Optics, where he led the marketing and launch of new laser systems globally.